Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.383
+0.015 (4.19%)
At close: May 17, 2024, 4:00 PM
0.388
+0.005 (1.20%)
After-hours: May 17, 2024, 7:58 PM EDT
Lyra Therapeutics Stock Forecast
LYRA's stock price has decreased by -86.02% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lyra Therapeutics stock have an average target of 4.50, with a low estimate of 0.50 and a high estimate of 11. The average target predicts an increase of 1,074.93% from the current stock price of 0.38.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LYRA stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +422.19% | May 7, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +30.55% | May 7, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +3,033.16% | May 1, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +2,772.06% | Mar 25, 2024 |
Financial Forecast
Revenue This Year
1.41M
from 1.56M
Decreased by -9.69%
Revenue Next Year
797.13K
from 1.41M
Decreased by -43.35%
EPS This Year
-1.03
from -1.26
EPS Next Year
-1.14
from -1.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1M | 1.7M | 44.3M | 69.8M | 176.8M |
| Avg | 1.4M | 797,130 | 30.9M | 67.8M | 156.7M |
| Low | n/a | n/a | 18.0M | 65.1M | 136.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.8% | 19.4% | 5,458.7% | 125.9% | 160.9% |
| Avg | -9.7% | -43.3% | 3,774.3% | 119.5% | 131.2% |
| Low | - | - | 2,156.5% | 110.9% | 100.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.90 | -0.80 | -1.69 | -0.82 |
| Avg | -1.03 | -1.14 | -1.73 | -1.29 |
| Low | -1.19 | -1.47 | -1.74 | -1.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.